Media interviews1.15.13
•
0 likes•155 views
This document provides links to interviews and summaries of interviews with pharmaceutical industry leaders from companies such as Pfizer, Genentech, Bayer Healthcare, Cardinal Healthcare, Shire, and the HBA Global Board. The interviews include a television interview on treatments for atopic dermatitis from 2012 and red carpet interviews from the 2012 HBA Woman of the Year event that feature the leaders discussing their roles and companies.
Report
Share
Report
Share
Recommended
Media Interviews10.12
This document provides links to various interviews and videos from 2012 featuring pharmaceutical industry leaders. It includes a television interview about treatments for atopic dermatitis, as well as red carpet interviews from the 2012 HBA Woman of the Year event with executives from Pfizer, Genentech, Bayer Healthcare, Cardinal Health, Shire, Physician Detailing Incorporated, and HBA Global Board.
Medical Affairs Asia 2012
International and regional experts coming together
to discuss strategies and opportunities in the Medical
Affairs function
• Unique insights and case studies on experiences in
the Asia market, successful programmes and best
practices
• Detailed and practical workshop to complement
your learning and networking experience
MENA Pharma excellence Congress
This document provides information about the MENA Pharma Excellence Congress taking place from March 28-31, 2016 in Dubai, UAE. The conference will discuss key issues facing the pharmaceutical industry through presentations and panel discussions. It will address topics like regulatory challenges, creating business models, improving sales and marketing, and enhancing industry-government collaboration. Experts from pharmaceutical companies and governments will speak. Attendees can choose between different registration packages that include access to workshops and presentations.
EIU Value Challenge
This document discusses the "value challenge" facing the biopharmaceutical industry. It conducted a global survey of 399 life sciences executives and interviewed experts. The key findings are:
1) Demonstrating value is a significant and long-term challenge for most drug companies worldwide. While financial pressures have increased scrutiny, demands for proof of value have evolved for decades.
2) Many industry stakeholders, especially biopharmaceutical companies, lack confidence in their ability to respond effectively to the value challenge.
3) Companies are experimenting with various strategies to address value but have not converged on any single approach across business models, R&D, or commercial strategies.
BioMs 2008 Annual Report
BioMS Medical is developing dirucotide to treat progressive multiple sclerosis (MS). They are expecting results in the second half of 2009 from their phase III MAESTRO-01 trial testing dirucotide on 611 patients with secondary progressive MS. If successful, it would be the first treatment approved for this population. BioMS has invested $180 million and over 1,300 patients have participated in clinical trials of dirucotide to date. A partnership with Eli Lilly provides funding to complete development and commercialization of dirucotide globally if the phase III trials are successful.
Menu labelling for reducing energy ordered and consumed: What’s the evidence?
Health Evidence hosted a 60 minute webinar examining the effectiveness of menu labelling on reducing energy consumption. Click here for access to the audio recording for this webinar: https://youtu.be/ju5uucv3dEE
Sofia Lourenço and Jodie Anne Littlewood from the Danish Cancer Society led the session and presented findings from their recent review:
Littlewood J, Lourenço S, Iversen C, & Hansen G. (2016).Menu labelling is effective in reducing energy ordered and consumed: A systematic review and meta-analysis of recent studies. Public Health Nutrition, 19(12), 2106-2121.
http://www.healthevidence.org/view-article.aspx?a=menu-labelling-effective-reducing-energy-ordered-consumed-systematic-review-meta-29695
Menu labelling is a tool to inform consumers of energy content of meals in the eating-out environment and help consumers make informed decisions. This review examines the effectiveness of menu labelling to reduce energy consumption. Fifteen studies, including 17, 859 participants are included in this review. Evidence suggests that menu labelling reduces overall energy consumed and ordered in the eating-out environment. This webinar examined the effectiveness of menu labelling to reduce energy consumed in the eating-out environment.
E-Marketing in the Pharmaceutical Industry (a student presentation)
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Biosimilars Asia
Why you should attend:
1. Learn from in-depth case studies on strategic partnering and effective collaboration
2. Explore new business opportunities and strategies to reach the biosimilars market in the region
3. Gain insights into the regulatory landscape for biosimilars in China, India, Korea, Taiwan and more
4. Gather the latest market intelligence and analysis and identify new trends and opportunities in Biosimilars R&D, contract manufacturing and commercialization in Asia
报名参加的五大理由
1. 深入学习有关与亚洲公司建立战略合作和有效协作的案例研究
2. 探索新的商机和战略，以便进入当地的生物仿制药市场
3. 深入了解中国、印度、韩国、台湾以及更多国家或地区的生物仿制药监管形势
4. 收集最新的市场情报和分析，确定生物仿制药研发、合同制造和商业化在亚洲的新趋势和机会
Hear about:
Biopharma Regulatory Updates and Development
Victoria Elegant, VP Medical & Regulatory Affairs, Baxter, China
Andrea Laslop, Head of Scientific Office, Austrian Agency for Food and Health Safety, Austrian Member, European Medicines Agency
Arvind Mishra, Global Head of Quality & Regulatory & Head of Strategic Business Unit, Biologicals, Cadilla Pharmaceutical, India
Advances in Biosimilars R&D
Jeffrey Su, CSO, Cytovance Biologics, USA
Wenzhi Tian, CEO, Huabo Biopharma, China
Ming Wang, President and COO, Gan & Lee Pharmaceuticals, China
Feng Li, CEO, Beijing Mabworks, China
Shaligram Rane, Vice President for Quality, Intas Pharmaceuticals, India
Understanding Obstacles and Hurdles for Entering the Biosimilars Market
Khai Meng Ang, Vice President Asia, Hospira, China
Jason Li, Senior Director, Genor Biopharma, China
Sachidananda Moorthy, Vice President - Clinical Research, Medical and Regulatory Affairs, Avesthagen, India
Sameer Agarwal, Senior Vice President, Business Center Strategic Marketing, Business Unit Generic Drugs & Standard Solutions, Fresenius Kabi, Germany
What can Asia Learn from Global Biosimilars Development and Litigation?
Li Cai, Regional R&D Counsel, Pfizer, China
Vivek Mittal, Head – Legal, Lupin, India
Viren Mahurkar, Managing Director, HitechnRock Advisors, Singapore
http://www.biosimilarsasia.com
Pre-Conference Special Focus Day, 20 May 2014
Clinical Development for Biosimilars
Post-Conference Workshops, 23 May 2014
A: Challenges in Demonstrating Biosimilarity and Interchangeability of Biosimilar Products
B: Successfully Bringing Biosimilars to Market
会前特别关注日，2014 年 5 月 20 日
生物仿制药的临床开发
会后研讨会，2014 年 5 月 23 日
A：在展示生物仿制药产品的生物相似性和可互换性方面所面临的挑战
B：成功地将生物仿制药推向市场
Recommended
Media Interviews10.12
This document provides links to various interviews and videos from 2012 featuring pharmaceutical industry leaders. It includes a television interview about treatments for atopic dermatitis, as well as red carpet interviews from the 2012 HBA Woman of the Year event with executives from Pfizer, Genentech, Bayer Healthcare, Cardinal Health, Shire, Physician Detailing Incorporated, and HBA Global Board.
Medical Affairs Asia 2012
International and regional experts coming together
to discuss strategies and opportunities in the Medical
Affairs function
• Unique insights and case studies on experiences in
the Asia market, successful programmes and best
practices
• Detailed and practical workshop to complement
your learning and networking experience
MENA Pharma excellence Congress
This document provides information about the MENA Pharma Excellence Congress taking place from March 28-31, 2016 in Dubai, UAE. The conference will discuss key issues facing the pharmaceutical industry through presentations and panel discussions. It will address topics like regulatory challenges, creating business models, improving sales and marketing, and enhancing industry-government collaboration. Experts from pharmaceutical companies and governments will speak. Attendees can choose between different registration packages that include access to workshops and presentations.
EIU Value Challenge
This document discusses the "value challenge" facing the biopharmaceutical industry. It conducted a global survey of 399 life sciences executives and interviewed experts. The key findings are:
1) Demonstrating value is a significant and long-term challenge for most drug companies worldwide. While financial pressures have increased scrutiny, demands for proof of value have evolved for decades.
2) Many industry stakeholders, especially biopharmaceutical companies, lack confidence in their ability to respond effectively to the value challenge.
3) Companies are experimenting with various strategies to address value but have not converged on any single approach across business models, R&D, or commercial strategies.
BioMs 2008 Annual Report
BioMS Medical is developing dirucotide to treat progressive multiple sclerosis (MS). They are expecting results in the second half of 2009 from their phase III MAESTRO-01 trial testing dirucotide on 611 patients with secondary progressive MS. If successful, it would be the first treatment approved for this population. BioMS has invested $180 million and over 1,300 patients have participated in clinical trials of dirucotide to date. A partnership with Eli Lilly provides funding to complete development and commercialization of dirucotide globally if the phase III trials are successful.
Menu labelling for reducing energy ordered and consumed: What’s the evidence?
Health Evidence hosted a 60 minute webinar examining the effectiveness of menu labelling on reducing energy consumption. Click here for access to the audio recording for this webinar: https://youtu.be/ju5uucv3dEE
Sofia Lourenço and Jodie Anne Littlewood from the Danish Cancer Society led the session and presented findings from their recent review:
Littlewood J, Lourenço S, Iversen C, & Hansen G. (2016).Menu labelling is effective in reducing energy ordered and consumed: A systematic review and meta-analysis of recent studies. Public Health Nutrition, 19(12), 2106-2121.
http://www.healthevidence.org/view-article.aspx?a=menu-labelling-effective-reducing-energy-ordered-consumed-systematic-review-meta-29695
Menu labelling is a tool to inform consumers of energy content of meals in the eating-out environment and help consumers make informed decisions. This review examines the effectiveness of menu labelling to reduce energy consumption. Fifteen studies, including 17, 859 participants are included in this review. Evidence suggests that menu labelling reduces overall energy consumed and ordered in the eating-out environment. This webinar examined the effectiveness of menu labelling to reduce energy consumed in the eating-out environment.
E-Marketing in the Pharmaceutical Industry (a student presentation)
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Biosimilars Asia
Why you should attend:
1. Learn from in-depth case studies on strategic partnering and effective collaboration
2. Explore new business opportunities and strategies to reach the biosimilars market in the region
3. Gain insights into the regulatory landscape for biosimilars in China, India, Korea, Taiwan and more
4. Gather the latest market intelligence and analysis and identify new trends and opportunities in Biosimilars R&D, contract manufacturing and commercialization in Asia
报名参加的五大理由
1. 深入学习有关与亚洲公司建立战略合作和有效协作的案例研究
2. 探索新的商机和战略，以便进入当地的生物仿制药市场
3. 深入了解中国、印度、韩国、台湾以及更多国家或地区的生物仿制药监管形势
4. 收集最新的市场情报和分析，确定生物仿制药研发、合同制造和商业化在亚洲的新趋势和机会
Hear about:
Biopharma Regulatory Updates and Development
Victoria Elegant, VP Medical & Regulatory Affairs, Baxter, China
Andrea Laslop, Head of Scientific Office, Austrian Agency for Food and Health Safety, Austrian Member, European Medicines Agency
Arvind Mishra, Global Head of Quality & Regulatory & Head of Strategic Business Unit, Biologicals, Cadilla Pharmaceutical, India
Advances in Biosimilars R&D
Jeffrey Su, CSO, Cytovance Biologics, USA
Wenzhi Tian, CEO, Huabo Biopharma, China
Ming Wang, President and COO, Gan & Lee Pharmaceuticals, China
Feng Li, CEO, Beijing Mabworks, China
Shaligram Rane, Vice President for Quality, Intas Pharmaceuticals, India
Understanding Obstacles and Hurdles for Entering the Biosimilars Market
Khai Meng Ang, Vice President Asia, Hospira, China
Jason Li, Senior Director, Genor Biopharma, China
Sachidananda Moorthy, Vice President - Clinical Research, Medical and Regulatory Affairs, Avesthagen, India
Sameer Agarwal, Senior Vice President, Business Center Strategic Marketing, Business Unit Generic Drugs & Standard Solutions, Fresenius Kabi, Germany
What can Asia Learn from Global Biosimilars Development and Litigation?
Li Cai, Regional R&D Counsel, Pfizer, China
Vivek Mittal, Head – Legal, Lupin, India
Viren Mahurkar, Managing Director, HitechnRock Advisors, Singapore
http://www.biosimilarsasia.com
Pre-Conference Special Focus Day, 20 May 2014
Clinical Development for Biosimilars
Post-Conference Workshops, 23 May 2014
A: Challenges in Demonstrating Biosimilarity and Interchangeability of Biosimilar Products
B: Successfully Bringing Biosimilars to Market
会前特别关注日，2014 年 5 月 20 日
生物仿制药的临床开发
会后研讨会，2014 年 5 月 23 日
A：在展示生物仿制药产品的生物相似性和可互换性方面所面临的挑战
B：成功地将生物仿制药推向市场
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014Medical Science Liaison Society
Dr. Samuel Dyer will be moderating the 2nd Annual Medical Affairs Leaders Forum Asia in Hong Kong on August 5th-6th, 2014.
Dr. Samuel Dyer will also be speaking at the event and will represent the Medical Science Liaison Society.Anthony Presentation DIA Florida Ctd Nov2007
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
The Population Health Management Market 2015
Population health management is a problem term because it can mean something different to each person who hears it. However, I believe that the words capture the overall spirit and energy of healthcare reform in a unique way. Providers are thinking big when it comes to a patient’s engagement, responsibility, and preventative care, and they’re leveraging technology to do it. I discuss an overall picture of PHM, present some useful technology, and tell a few PHM stories herein.
Emerging Importance of the Managed Care Liaison
This document discusses the role of the Managed Care Liaison (MCL) and how their role may evolve. It notes that the MCL operates at the intersection of medical science and business. The document outlines the MCL's current responsibilities, which include maintaining account knowledge, integrating clinical value propositions, and operating independently across multiple networks. It also discusses trends in healthcare like increasing emphasis on value demonstration and quality metrics that may impact the MCL role going forward. The MCL is poised to take on an advisory role in these changing landscapes.
The Digital Innovation Award - DocDoc
DocDoc is a platform that uses AI to help patients find the right doctor by providing personalized recommendations based on a patient's unique medical needs, healthcare costs, and doctor quality metrics. It analyzes vast amounts of medical data to match patients with high quality doctors who are experts in their specific condition or procedure, while also considering price and patient experience factors. Pilot programs with insurers have shown DocDoc can significantly reduce healthcare costs through better doctor selection, improve patient outcomes by steering people to higher quality providers, and achieve nearly 90% patient satisfaction rates.
The Future Health Ecosystem Today
An industry-wide survey of the health ecosystem. By looking at leading operating models that are representative of the future health ecosystem, the viewer can get a handle on how the future will look.
2014 cme disclosures
This continuing medical education activity was jointly sponsored by Tift Regional Medical Center and SOWEGA-AHEC. The activity was planned in accordance with accreditation standards and policies. Tift Regional Medical Center is accredited to provide up to 13.75 hours of continuing education credits for physicians. Planning committee members disclosed any relevant financial relationships, with one planner disclosing an employee relationship with Tift Regional Medical Center. Speaker disclosures were also provided.
2014 cme disclosures
This continuing medical education activity was jointly sponsored by Tift Regional Medical Center and SOWEGA-AHEC. The activity was planned and implemented according to accreditation standards and policies. Tift Regional Medical Center is accredited to provide up to 13.75 hours of continuing education credits for physicians. Planning committee members disclosed any relevant financial relationships, with one employee of Tift Regional Medical Center disclosed. Speaker disclosures were provided.
Leaders in Healthcare Conference
The Leaders in Healthcare Conference at the Arab Health Congress 2015 is one of the most prestigious, high-level medical conferences across the globe. Attracting a senior level audience of CEOs, directors and ministerial advisors, this one-day conference gathers a host of industry leaders to address and discuss the region's most pressing matters.
This years theme will focus on 'Advancing Geriatric Care in the Middle East' and will once again host Chairperson of Dubai Healthcare City Authority HRH Princess Haya Bint Al Hussein, wife of HH Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai as the official opening keynote address.
Delegates will have the opportunity to hear from some of the industry's leading medical experts from across the region and the globe and they will be able to ask their most burning questions through interactive panel discussions.
Health Space Video
The document outlines a business development plan for HealthSpaceVideo, an online health information and support platform that will allow users to share health stories through video. The plan details objectives to empower patients through access to information and community, and strategies for launching the website, attracting funding, and establishing a non-profit foundation to support the initiative over three years.
Medexpo2012 brochure
The document summarizes a forum on healthcare in Saudi Arabia that will discuss innovative solutions, investment opportunities, and public-private partnerships. The forum will feature presentations from healthcare leaders in Saudi Arabia and include sessions on strategies to meet future demands, improving patient care with technology, achieving operational excellence, and regional best practices. Attendees will include executives from hospitals and clinics who want to learn strategies for quality healthcare, technology integration, and partnership opportunities in Saudi Arabia's growing healthcare sector.
Women's health network dr
The document discusses the benefits of advertising in OBG Management, a medical journal focused on women's health. It highlights that OBG Management has been ranked #1 in several readership metrics for 5 straight years. It also provides details on the journal's circulation, editorial board, peer review process, and multimedia capabilities. Promotion Plus is introduced, which offers bundled advertising discounts across print, online, audio, and video channels.
Brochure v3
This document provides information about the 14th Annual eyeforpharma Philadelphia Summit taking place May 2-3, 2016 in Philadelphia. The summit will feature keynote speakers and sessions focused on developing a new commercial model built on strategic customer partnerships that prioritize patient value. Attendees will learn how to disrupt and invigorate sales departments, create multichannel strategies, and deliver patient-centered care. Over two days, industry leaders will discuss practical approaches for engaging customers and moving commercial strategies beyond tactics.
Living Well - Fall 2017
Explore ways to stay strong in the face of life's challenges in this edition of Living Well magazine.
Diagnosing Healthcare in the GCC
The document discusses the rising prevalence of non-communicable diseases (NCDs) like obesity, diabetes, heart disease and cancer in GCC countries due to rapid lifestyle changes following increased oil wealth. It notes high rates of obesity, reaching over 75% of adults in some countries, and diabetes affecting around 1 in 5 adults in Saudi Arabia and Kuwait. This shift is attributed to diets high in sugar and processed foods replacing traditional diets, along with more sedentary lifestyles. The report argues early diagnosis and preventative healthcare are needed to curb NCDs and help GCC countries achieve their economic goals.
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
This report provides an overview and analysis of the global clinical nutrition products market, which includes infant, enteral, and parenteral nutrition. It covers market sizes and forecasts through 2016 for these segments. The report is based on interviews and research on industry trends, issues, leading companies, and regulatory environment. It finds that the clinical nutrition market is growing due to an aging population with chronic diseases requiring specialized nutrition support. However, reimbursement challenges and cost containment are issues affecting the industry. Major companies profiled that dominate the market include Abbott, Baxter, Danone, Fresenius Kabi, and Nestle.
Real World Evidence HEOR and Post Approval Studies Summit
This executive level summit explores strategies for innovation in the evolving world of data. Hear from a variety of stakeholder perspectives including industry, regulatory, CRO, and related organizations who will address the key strategies for success in the ever-changing post-marketing environment. The agenda features cutting-edge methods and in-depth case studies that provide pragmatic, real world takeaways. Attend this summit to gain critical insights and collaborate with your peers on the best methods and strategies for post-approval success.
http://www.worldcongress.com/events/PB14019/
Biosimilars & biobetters usa
This document provides information about the "Biosimilars & Biobetters USA 2014" conference to be held on April 7-8, 2014 in Iselin, New Jersey. The conference will focus on regulatory issues, commercialization strategies, and product development for biosimilars and biobetters in the US market. It includes an agenda with speaker information, session topics, and registration details. There will also be two post-conference workshops on April 9th on differentiation strategies for generics and launching biosimilars. The document promotes the conference and workshops as an opportunity to gain industry insights, network with leaders, and learn how to successfully develop and launch biosimilar products in the US.
SMi Group's Biosimilars & Biobetters conference USA
This document provides information about the "Biosimilars & Biobetters USA 2014" conference to be held on April 7-8, 2014 in Iselin, New Jersey. The conference will focus on regulatory issues, commercialization strategies, and product development for biosimilars and biobetters in the US market. It includes an agenda with speaker information, session topics, and registration details. There will also be two post-conference workshops on April 9th on differentiation strategies for generics and launching biosimilars. The document aims to provide attendees with up-to-date insights and networking opportunities in the biosimilars industry.
Mdd080813
This document provides a summary of news stories from the August 8, 2013 issue of Medical Device Daily. The stories include:
1) Medtronic implanted its new deep brain stimulation plus sensing system that enables sensing and recording of select brain activity while providing targeted therapy, which could change the treatment of neurological disorders.
2) A study in the UK found that showing cardiologists a quantification of coronary lesion severity changed treatment plans for 26% of patients, highlighting the diagnostic value of fractional flow reserve.
3) FDA finalized guidance on clinical trial site monitoring that provides greater details on responsibilities when a sponsor hands off monitoring work to a contract research organization.
More Related Content
Similar to Media interviews1.15.13
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014Medical Science Liaison Society
Dr. Samuel Dyer will be moderating the 2nd Annual Medical Affairs Leaders Forum Asia in Hong Kong on August 5th-6th, 2014.
Dr. Samuel Dyer will also be speaking at the event and will represent the Medical Science Liaison Society.Anthony Presentation DIA Florida Ctd Nov2007
Creating a business process that is accurate, predictable, and capable of
meeting the changing needs for disclosing information about clinical trials
in multiple study registries and results databases is difficult. Companies
need to leverage their current clinical trial process, determine if the disclosure
steps will be centralized or decentralized, determine how much to
leverage technology, and decide whether, and how, to use outside
resources. During this session, we will hear how a large pharma, a small
biopharmaceutical company, and a device company developed their clinical
trial disclosure business process.
The Population Health Management Market 2015
Population health management is a problem term because it can mean something different to each person who hears it. However, I believe that the words capture the overall spirit and energy of healthcare reform in a unique way. Providers are thinking big when it comes to a patient’s engagement, responsibility, and preventative care, and they’re leveraging technology to do it. I discuss an overall picture of PHM, present some useful technology, and tell a few PHM stories herein.
Emerging Importance of the Managed Care Liaison
This document discusses the role of the Managed Care Liaison (MCL) and how their role may evolve. It notes that the MCL operates at the intersection of medical science and business. The document outlines the MCL's current responsibilities, which include maintaining account knowledge, integrating clinical value propositions, and operating independently across multiple networks. It also discusses trends in healthcare like increasing emphasis on value demonstration and quality metrics that may impact the MCL role going forward. The MCL is poised to take on an advisory role in these changing landscapes.
The Digital Innovation Award - DocDoc
DocDoc is a platform that uses AI to help patients find the right doctor by providing personalized recommendations based on a patient's unique medical needs, healthcare costs, and doctor quality metrics. It analyzes vast amounts of medical data to match patients with high quality doctors who are experts in their specific condition or procedure, while also considering price and patient experience factors. Pilot programs with insurers have shown DocDoc can significantly reduce healthcare costs through better doctor selection, improve patient outcomes by steering people to higher quality providers, and achieve nearly 90% patient satisfaction rates.
The Future Health Ecosystem Today
An industry-wide survey of the health ecosystem. By looking at leading operating models that are representative of the future health ecosystem, the viewer can get a handle on how the future will look.
2014 cme disclosures
This continuing medical education activity was jointly sponsored by Tift Regional Medical Center and SOWEGA-AHEC. The activity was planned in accordance with accreditation standards and policies. Tift Regional Medical Center is accredited to provide up to 13.75 hours of continuing education credits for physicians. Planning committee members disclosed any relevant financial relationships, with one planner disclosing an employee relationship with Tift Regional Medical Center. Speaker disclosures were also provided.
2014 cme disclosures
This continuing medical education activity was jointly sponsored by Tift Regional Medical Center and SOWEGA-AHEC. The activity was planned and implemented according to accreditation standards and policies. Tift Regional Medical Center is accredited to provide up to 13.75 hours of continuing education credits for physicians. Planning committee members disclosed any relevant financial relationships, with one employee of Tift Regional Medical Center disclosed. Speaker disclosures were provided.
Leaders in Healthcare Conference
The Leaders in Healthcare Conference at the Arab Health Congress 2015 is one of the most prestigious, high-level medical conferences across the globe. Attracting a senior level audience of CEOs, directors and ministerial advisors, this one-day conference gathers a host of industry leaders to address and discuss the region's most pressing matters.
This years theme will focus on 'Advancing Geriatric Care in the Middle East' and will once again host Chairperson of Dubai Healthcare City Authority HRH Princess Haya Bint Al Hussein, wife of HH Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai as the official opening keynote address.
Delegates will have the opportunity to hear from some of the industry's leading medical experts from across the region and the globe and they will be able to ask their most burning questions through interactive panel discussions.
Health Space Video
The document outlines a business development plan for HealthSpaceVideo, an online health information and support platform that will allow users to share health stories through video. The plan details objectives to empower patients through access to information and community, and strategies for launching the website, attracting funding, and establishing a non-profit foundation to support the initiative over three years.
Medexpo2012 brochure
The document summarizes a forum on healthcare in Saudi Arabia that will discuss innovative solutions, investment opportunities, and public-private partnerships. The forum will feature presentations from healthcare leaders in Saudi Arabia and include sessions on strategies to meet future demands, improving patient care with technology, achieving operational excellence, and regional best practices. Attendees will include executives from hospitals and clinics who want to learn strategies for quality healthcare, technology integration, and partnership opportunities in Saudi Arabia's growing healthcare sector.
Women's health network dr
The document discusses the benefits of advertising in OBG Management, a medical journal focused on women's health. It highlights that OBG Management has been ranked #1 in several readership metrics for 5 straight years. It also provides details on the journal's circulation, editorial board, peer review process, and multimedia capabilities. Promotion Plus is introduced, which offers bundled advertising discounts across print, online, audio, and video channels.
Brochure v3
This document provides information about the 14th Annual eyeforpharma Philadelphia Summit taking place May 2-3, 2016 in Philadelphia. The summit will feature keynote speakers and sessions focused on developing a new commercial model built on strategic customer partnerships that prioritize patient value. Attendees will learn how to disrupt and invigorate sales departments, create multichannel strategies, and deliver patient-centered care. Over two days, industry leaders will discuss practical approaches for engaging customers and moving commercial strategies beyond tactics.
Living Well - Fall 2017
Explore ways to stay strong in the face of life's challenges in this edition of Living Well magazine.
Diagnosing Healthcare in the GCC
The document discusses the rising prevalence of non-communicable diseases (NCDs) like obesity, diabetes, heart disease and cancer in GCC countries due to rapid lifestyle changes following increased oil wealth. It notes high rates of obesity, reaching over 75% of adults in some countries, and diabetes affecting around 1 in 5 adults in Saudi Arabia and Kuwait. This shift is attributed to diets high in sugar and processed foods replacing traditional diets, along with more sedentary lifestyles. The report argues early diagnosis and preventative healthcare are needed to curb NCDs and help GCC countries achieve their economic goals.
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
This report provides an overview and analysis of the global clinical nutrition products market, which includes infant, enteral, and parenteral nutrition. It covers market sizes and forecasts through 2016 for these segments. The report is based on interviews and research on industry trends, issues, leading companies, and regulatory environment. It finds that the clinical nutrition market is growing due to an aging population with chronic diseases requiring specialized nutrition support. However, reimbursement challenges and cost containment are issues affecting the industry. Major companies profiled that dominate the market include Abbott, Baxter, Danone, Fresenius Kabi, and Nestle.
Real World Evidence HEOR and Post Approval Studies Summit
This executive level summit explores strategies for innovation in the evolving world of data. Hear from a variety of stakeholder perspectives including industry, regulatory, CRO, and related organizations who will address the key strategies for success in the ever-changing post-marketing environment. The agenda features cutting-edge methods and in-depth case studies that provide pragmatic, real world takeaways. Attend this summit to gain critical insights and collaborate with your peers on the best methods and strategies for post-approval success.
http://www.worldcongress.com/events/PB14019/
Biosimilars & biobetters usa
This document provides information about the "Biosimilars & Biobetters USA 2014" conference to be held on April 7-8, 2014 in Iselin, New Jersey. The conference will focus on regulatory issues, commercialization strategies, and product development for biosimilars and biobetters in the US market. It includes an agenda with speaker information, session topics, and registration details. There will also be two post-conference workshops on April 9th on differentiation strategies for generics and launching biosimilars. The document promotes the conference and workshops as an opportunity to gain industry insights, network with leaders, and learn how to successfully develop and launch biosimilar products in the US.
SMi Group's Biosimilars & Biobetters conference USA
This document provides information about the "Biosimilars & Biobetters USA 2014" conference to be held on April 7-8, 2014 in Iselin, New Jersey. The conference will focus on regulatory issues, commercialization strategies, and product development for biosimilars and biobetters in the US market. It includes an agenda with speaker information, session topics, and registration details. There will also be two post-conference workshops on April 9th on differentiation strategies for generics and launching biosimilars. The document aims to provide attendees with up-to-date insights and networking opportunities in the biosimilars industry.
Mdd080813
This document provides a summary of news stories from the August 8, 2013 issue of Medical Device Daily. The stories include:
1) Medtronic implanted its new deep brain stimulation plus sensing system that enables sensing and recording of select brain activity while providing targeted therapy, which could change the treatment of neurological disorders.
2) A study in the UK found that showing cardiologists a quantification of coronary lesion severity changed treatment plans for 26% of patients, highlighting the diagnostic value of fractional flow reserve.
3) FDA finalized guidance on clinical trial site monitoring that provides greater details on responsibilities when a sponsor hands off monitoring work to a contract research organization.
Similar to Media interviews1.15.13 (20)
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral ...
Real World Evidence HEOR and Post Approval Studies Summit
Real World Evidence HEOR and Post Approval Studies Summit
SMi Group's Biosimilars & Biobetters conference USA
SMi Group's Biosimilars & Biobetters conference USA
Media interviews1.15.13
- 1. Television Interview- The Balancing Act at O2 Media: Treatments for Atopic Dermatitis, 2012 ◦ http://www.thebalancingact.com/story/?id=3813 2012 HBA Woman of the Year Event: Red Carpet Interviews with Pharma Industry Leaders ◦ Freda Lewis-Hall, Chief Medical Officer/ EVP Pfizer http://youtu.be/hfo23_KNE_s ◦ Evan Morris, VP, Government Affairs, Genentech http://youtu.be/B_eaHCBUapw ◦ Pam Cyrus, VP, Head of Medical Affairs, US, Bayer Healthcare http://youtu.be/JprMDttZE8s ◦ Megan Fitzgerald, President, Pharmaceutical Group, Cardinal Healthcare http://youtu.be/OpIqsVoVQWM ◦ Debra Weiss, VP Quality Assurance, Shire http://youtu.be/z84Bbk7aiV8 ◦ Linda DaSilva, Director, Conference Platforms, HBA Global Board http://youtu.be/aMCDJCRTG4Q